Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 77 Breast Neoplasms 59 Prostatic Neoplasms 30 Triple Negative Breast Neoplasms 26 Fallopian Tube Neoplasms 22 Neoplasms 21 Neoplasm Metastasis 18 Pancreatic Neoplasms 17 Endometrial Neoplasms 16 Small Cell Lung Carcinoma 13 Sarcoma 9 Carcinoma, Ovarian Epithelial 9 Carcinoma, Non-Small-Cell Lung 9 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Recurrence 8 Lung Neoplasms 7 Glioma 7 Fanconi Anemia, Complementation Group D1 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Glioblastoma 6 Colorectal Neoplasms 6 Lymphoma, Non-Hodgkin 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Solid Tumors 4 Neuroendocrine Tumors 4 Metastatic Castration-resistant Prostate Cancer 4 Carcinoma, Squamous Cell 4 Advanced Solid Tumors 4

Interventions

aldesleukin 38 Sunitinib 34 Cyclophosphamide 29 Nivolumab 27 pembrolizumab 25 Interferon-alpha 25 Everolimus 24 Sorafenib 20 fludarabine phosphate 19 Bevacizumab 19 Interleukin-2 17 Ipilimumab 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 Filgrastim 15 Radiotherapy 14 Axitinib 14 cabozantinib 13 temsirolimus 10 fludarabine 10 Radiosurgery 10 Doxorubicin 10 Carboplatin 10 sargramostim 8 belzutifan 8 Fluorouracil 8 Etoposide 8 Chemotherapy, Adjuvant 8 Magnetic Resonance Spectroscopy 7 Ifosfamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03786796 2025-03-13

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡